Unveiling the Facets of Post-Sepsis Syndrome: Physical and Neuropsyc…

Houston Methodist

D. Moran

Treatment Strategies for Hematocrit Control in PV

Insights from 2023 ASH Annual Meeting

A. Zhou

Safety Profile of Ruxolitinib in Patients With MF

Icahn School of Medicine at Mount Sinai

D. Tremblay

Prevalence and Prediction of Ruxolitinib Treatment Emergent Thromboc…

Insights from 2023 ASH Annual Meeting

D. Tremblay

IDWeek 2024 Insights: Early Discontinuation of Empiric Antibiotics f…

IDWeek 2024 Insights

S. Castejon Ramirez

Treatment-Related Quality of Life in MF

Winship Cancer Institute - Emory University

A. Hunter

Leukemia Tumor Board at the Tisch Cancer Institute at Mount Sinai: 6…

Tisch Cancer Institute at Mount Sinai

M. Metzger

Diagnosis and Goals of Therapy in PV

Northwestern Medicine Oncology and Hematology

B. Stein

MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…

ASH 2022 Conference Coverage

M. McMullin

Using Cytoreductive Therapy to Prevent Cardiovascular Events in Pati…

Monia Marchetti

Polycythemia Vera: Disease Overview, Treatment Landscape, and Curren…

Jerry Spivak

Evolving Syndrome of MOF into PICS-CCI

Houston Methodist

F. Moore

Symptomatic Profiles of Patients With Polycythemia Vera: Implication…

Alexander Coltoff

Herpes Zoster: Prevention and Management

Stephanie James

Presentation of Herpes Zoster (Shingles) After COVID-19 Vaccination:…

H.L. Greenberg

A Real-World Evaluation of the Association Between Elevated Blood Co…

Aaron Gerds

Leukemia Tumor Board at the Tisch Cancer Institute at Mount Sinai: M…

Tisch Cancer Institute at Mount Sinai

D. Tremblay, J. Mascarenhas, R. Sheppard, A. Shih, I. Sarami

Splenomegaly in Polycythemia Vera: Clinical Significance and Relatio…

Richard T. Silver

Monkeypox 2022: Another Potential Public Health Crisis

Mayo Clinic Proceedings

N. Ranganath

Vaccine Effectiveness Against Influenza Illness in Children, Clinica…

MicrobeTV

D. Griffin, V. Racaniello